| Item Type | Name |
|
Concept
|
Anastomosis, Surgical
|
|
Concept
|
Alleles
|
|
Concept
|
Carcinoma, Squamous Cell
|
|
Concept
|
Bartholin's Glands
|
|
Concept
|
Feasibility Studies
|
|
Concept
|
Drug Administration Schedule
|
|
Concept
|
Neoplasm Staging
|
|
Concept
|
Rupture, Spontaneous
|
|
Concept
|
Sarcoidosis
|
|
Concept
|
Sarcoma
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Gynecologic Surgical Procedures
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Sulfonamides
|
|
Concept
|
Salvage Therapy
|
|
Concept
|
In Situ Hybridization
|
|
Concept
|
Disease-Free Survival
|
|
Concept
|
Patient Selection
|
|
Concept
|
Cross-Over Studies
|
|
Concept
|
Minimally Invasive Surgical Procedures
|
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
|
Concept
|
Cystadenocarcinoma, Serous
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Colon, Sigmoid
|
|
Concept
|
Cytoreduction Surgical Procedures
|
|
Concept
|
United States
|
|
Concept
|
United States Food and Drug Administration
|
|
Concept
|
Survival Rate
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Surgical Stomas
|
|
Concept
|
Sentinel Lymph Node Biopsy
|
|
Concept
|
Drug-Related Side Effects and Adverse Reactions
|
|
Concept
|
Second-Look Surgery
|
|
Concept
|
Follow-Up Studies
|
|
Academic Article
|
Local correction of extreme stomal prolapse following transverse loop colostomy.
|
|
Academic Article
|
Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer.
|
|
Academic Article
|
Outpatient platinum-taxane intraperitoneal chemotherapy regimen for ovarian cancer.
|
|
Academic Article
|
Is there a high-risk subgroup of stage I epithelial ovarian cancer that is most likely to benefit from 6 versus 3 cycles of adjuvant chemotherapy?
|
|
Academic Article
|
Evolution of the Gynecologic Oncology Group protocols in the treatment of epithelial ovarian cancer.
|
|
Academic Article
|
Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?
|
|
Academic Article
|
Factors influencing primary treatment of midline vulvar cancers.
|
|
Academic Article
|
Robotic hysterectomy and lymphadenectomy for endometrial cancer: technical aspects and details of success-the Ohio State University method.
|
|
Academic Article
|
The Significance of Para-Aortic Nodal Size and the Role of Adjuvant Systemic Chemotherapy in Cervical Cancer: An Institutional Experience.
|
|
Academic Article
|
Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062).
|
|
Academic Article
|
The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform.
|
|
Academic Article
|
Robotic hysterectomy and pelvic-aortic lymphadenectomy for endometrial cancer.
|
|
Academic Article
|
A detailed analysis of the learning curve: robotic hysterectomy and pelvic-aortic lymphadenectomy for endometrial cancer.
|
|
Academic Article
|
Factors associated with clinical trial screening failures in gynecologic oncology.
|
|
Academic Article
|
Adnexal masses requiring surgical intervention in women with advanced cervical cancer.
|
|
Academic Article
|
Risk of Occult Uterine Sarcoma in Women Undergoing Hysterectomy for Benign Indications.
|
|
Academic Article
|
Locally Advanced Cervical Cancer: Outcomes With Variable Adherence to Treatment.
|
|
Academic Article
|
Third-line Salvage Chemotherapy for Recurrent Carcinoma of the Cervix is Associated With Minimal Response Rate and High Toxicity.
|
|
Academic Article
|
The prevalence of occult endometrial cancer in women undergoing hysterectomy for benign indications.
|
|
Academic Article
|
Paclitaxel and Pazopanib in Ovarian Cancer-Reply.
|
|
Academic Article
|
New and Novel Therapies for Gynecologic Cancers.
|
|
Academic Article
|
Risk factors for anastomotic leak after recto-sigmoid resection for ovarian cancer.
|
|
Academic Article
|
Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancer.
|
|
Academic Article
|
Paratubal borderline serous tumors.
|
|
Academic Article
|
Isolated groin recurrence of vulvar cancer salvaged with multimodality therapy.
|
|
Academic Article
|
Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer.
|
|
Academic Article
|
Correlation of cone biopsy with findings at radical hysterectomy and use of adjuvant radiation therapy.
|
|
Academic Article
|
Outcomes of Treatment of Gestational Trophoblastic Neoplasia in a Primarily Indigent Urban Population.
|
|
Academic Article
|
Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.
|
|
Academic Article
|
Emphasis on Systemic Therapy in Women With Pelvic Bone Metastasis at Time of Diagnosis of Cervical Cancer.
|
|
Academic Article
|
Panniculectomy concurrent with anterior pelvic exenteration for recurrent cervical cancer.
|
|
Academic Article
|
CA125 decline in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy.
|
|
Academic Article
|
Metastatic squamous cell carcinoma of the vulva to the lung confirmed with allelotyping.
|
|
Academic Article
|
Robotic pelvic and aortic lymphadenectomy for endometrial cancer: the console surgeon's perspectives on surgical technique and directing the assistant.
|
|
Academic Article
|
Malignant ovarian germ cell tumor - role of surgical staging and gonadal dysgenesis.
|
|
Academic Article
|
Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
|
|
Academic Article
|
Ovarian involvement in endometrioid adenocarcinoma of uterus.
|
|
Academic Article
|
Hypoalbuminemia is a Predictive Factor for Fistula Formation in Recurrent Cervical Cancer.
|
|
Academic Article
|
Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial.
|
|
Academic Article
|
Olaparib in the treatment of ovarian cancer.
|
|
Academic Article
|
Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?
|
|
Academic Article
|
Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion.
|
|
Academic Article
|
Should we or should we not? Secondary debulking in ovarian cancer.
|
|
Academic Article
|
Ocular toxicity and mitigation strategies for antibody drug conjugates in gynecologic oncology.
|
|
Academic Article
|
Is there a role for secondary debulking in ovarian cancer? A review of the current literature.
|
|
Academic Article
|
Effect of Pevonedistat, an Investigational NEDD8-Activating Enzyme Inhibitor, on the QTc Interval in Patients With Advanced Solid Tumors.
|
|
Academic Article
|
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer.
|
|
Academic Article
|
Phase IIa Study of PLX2853 in Gynecologic Cancers With Known ARID1A Mutation and Phase Ib/IIa Study of PLX2853/Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer.
|
|
Academic Article
|
A Relative Bioavailability, Bioequivalence, and Food Effect Study of Niraparib Tablets in Patients with Advanced Solid Tumors.
|
|
Academic Article
|
Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer.
|